Online citations, reference lists, and bibliographies.
← Back to Search

Microarray Analysis Reveals A Major Direct Role Of DNA Copy Number Alteration In The Transcriptional Program Of Human Breast Tumors

J. Pollack, T. Sørlie, C. Perou, C. Rees, S. Jeffrey, P. Lønning, R. Tibshirani, D. Botstein, Anne-Lise Børresen-Dale, P. Brown
Published 2002 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Genomic DNA copy number alterations are key genetic events in the development and progression of human cancers. Here we report a genome-wide microarray comparative genomic hybridization (array CGH) analysis of DNA copy number variation in a series of primary human breast tumors. We have profiled DNA copy number alteration across 6,691 mapped human genes, in 44 predominantly advanced, primary breast tumors and 10 breast cancer cell lines. While the overall patterns of DNA amplification and deletion corroborate previous cytogenetic studies, the high-resolution (gene-by-gene) mapping of amplicon boundaries and the quantitative analysis of amplicon shape provide significant improvement in the localization of candidate oncogenes. Parallel microarray measurements of mRNA levels reveal the remarkable degree to which variation in gene copy number contributes to variation in gene expression in tumor cells. Specifically, we find that 62% of highly amplified genes show moderately or highly elevated expression, that DNA copy number influences gene expression across a wide range of DNA copy number alterations (deletion, low-, mid- and high-level amplification), that on average, a 2-fold change in DNA copy number is associated with a corresponding 1.5-fold change in mRNA levels, and that overall, at least 12% of all the variation in gene expression among the breast tumors is directly attributable to underlying variation in gene copy number. These findings provide evidence that widespread DNA copy number alteration can lead directly to global deregulation of gene expression, which may contribute to the development or progression of cancer.
This paper references
Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.
F. Forozan (2000)
Proc. Natl. Acad. Sci. USA 98
T Sorlie (2001)
10.1073/pnas.191367098
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T. Sørlie (2001)
Nat. Genet
T R Hughes (2000)
Cancer Res
J L Phillips (2001)
Silence of chromosomal amplifications in colon cancer.
P. Platzer (2002)
10.1038/77116
Widespread aneuploidy revealed by DNA microarray expression profiling
T. Hughes (2000)
10.1002/(SICI)1098-2264(199806)22:2<105::AID-GCC4>3.0.CO;2-0
Molecular cytogenetic analysis of consistent abnormalities at 8q12‐q22 in breast cancer
M. Schoenberg Fejzo (1998)
Proc. Natl. Acad. Sci. USA 94
R Li (1997)
10.1038/35021093
Molecular portraits of human breast tumours
C. Perou (2000)
10.1038/75985
Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
D. Albertson (2000)
10.1007/s001090050155
Pieces of the puzzle: expressed sequence tags and the catalog of human genes
G. Schuler (1997)
Cancer Res
P Platzer (2002)
Nat. Genet
J R Pollack (1999)
10.1038/12640
Genome-wide analysis of DNA copy-number changes using cDNA microarrays
J. Pollack (1999)
10.1002/gcc.2870120116
Genes, chromosomes & cancer
(1995)
10.1038/2524
High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
D. Pinkel (1998)
Biochem. J
D Rasnick (1999)
10.1073/PNAS.94.26.14506
Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells.
R. Li (1997)
10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I
Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances
S. Solinas-Toldo (1997)
10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.0.CO;2-X
Molecular cytogenetics of primary breast cancer by CGH
M. Tirkkonen (1998)
10.1042/BJ3400621
How aneuploidy affects metabolic control and causes cancer.
D. Rasnick (1999)
10.1126/SCIENCE.1359641
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.
A. Kallioniemi (1992)
The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis.
J. L. Phillips (2001)
10.1038/35057062
Initial sequencing and analysis of the human genome.
E. Lander (2001)
Nat. Genet
D G Albertson (2000)
Nat. Genet
D Pinkel (1998)
J. Mol. Med
G D Schuler (1997)
Cancer Res
F Forozan (2000)
Proc. Natl. Acad. Sci. USA 91
A Kallioniemi (1994)
10.1073/PNAS.91.6.2156
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.
A. Kallioniemi (1994)



This paper is referenced by
10.1016/j.molonc.2008.09.004
CAMK1D amplification implicated in epithelial–mesenchymal transition in basal‐like breast cancer
A. Bergamaschi (2008)
The detection of chromosomal abnormalities in human oocytes and preimplantation embryos by molecular cytogenetic analysis.
E. Fragouli (2005)
10.1371/journal.pbio.0020207
Lineage-Specific Gene Duplication and Loss in Human and Great Ape Evolution
A. Fortna (2004)
10.1016/J.EJCA.2004.08.021
Molecular portraits of breast cancer: tumour subtypes as distinct disease entities.
T. Sørlie (2004)
10.1038/sj.onc.1208383
Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications
M. Heidenblad (2005)
10.1097/01.pas.0000165528.78945.95
The Influence of Polysomy 17 on HER2 Gene and Protein Expression in Adenocarcinoma of the Breast: A Fluorescent In Situ Hybridization, Immunohistochemical, and Isotopic mRNA In Situ Hybridization Study
E. Downs-Kelly (2005)
10.1086/497343
High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs.
H. Slater (2005)
10.1111/J.1530-0277.2006.00081.X
DNA microarray and proteomic strategies for understanding alcohol action.
J. Sikela (2006)
10.1007/s10577-006-1055-4
The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study
J. Chaudhary (2006)
10.1016/J.CCR.2006.10.009
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
K. Chin (2006)
10.1007/978-1-59745-390-5_12
Integrated high-resolution genome-wide analysis of gene dosage and gene expression in human brain tumors.
D. Juric (2007)
10.1093/bioinformatics/btp603
Accurate confidence aware clustering of array CGH tumor profiles
Bart P. P. van Houte (2010)
10.1214/09-AOAS271
Regularized Multivariate Regression for Identifying Master Predictors with Application to Integrative Genomics Study of Breast Cancer.
J. Peng (2010)
Identifikation von disseminierungsrelevanten Genen und Genexpressionsmustern beim primären Mammakarzinom
Ute Wölfle (2003)
10.2144/03353DD01
Integration of genomic technologies for accelerated cancer drug development.
M. Basik (2003)
ALTERAÇÕES NO NÚMERO DE CÓPIAS GENÔMICAS EM CARCINOMAS DE MAMA
Ana Carolina Tomaz Tavares (2013)
TITLE : Epigenetic Basis for the Regulation of Estrogen Receptor Alpha Activity in Breast Cancer Cells PRINCIPAL INVESTIGATOR :
M. Lupien (2009)
10.1139/O07-072
Characterization of breast cancer by array comparative genomic hybridization.
J. Climent (2007)
10.1007/978-0-387-72430-0_10
Array Comparative Genomic Hybridization in Pathology
R. Ullmann (2008)
10.1534/genetics.108.090878
Aneuploidy: Cells Losing Their Balance
E. Torres (2008)
intcomp : Benchmarking pipeline for integrative cancer gene prioritization algorithms based on gene expression and copy number data
L. Lahti (2012)
10.1093/bioinformatics/btn465
Gene set enrichment analysis using linear models and diagnostics
A. Oron (2008)
Deletion of Chromosome 11 q Predicts Response to Anthracycline-Based Chemotherapy in Early Breast Cancer
J. Climent (2007)
10.1093/BIOSTATISTICS/KXH017
A method for calling gains and losses in array CGH data.
P. Wang (2005)
10.1158/0008-5472.CAN-05-0648
Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma.
A. Hui (2005)
10.1093/nar/gkm1143
Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data
Christiaan Klijn (2008)
10.1016/J.CCR.2006.03.019
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients.
D. Carrasco (2006)
10.1101/gr.117226.110
Assessment of palindromes as platforms for DNA amplification in breast cancer.
J. Guenthoer (2012)
10.5489/CUAJ.64
Combining differential expression, chromosomal and pathway analyses for the molecular characterization of renal cell carcinoma.
K. Furge (2007)
10.1002/0471142905.hg0413s46
The BAC Resource: Tools for Array CGH and FISH
N. J. Nowak (2005)
10.1016/j.crvi.2008.07.005
A prominent role for segmental duplications in modeling eukaryotic genomes.
R. Koszul (2009)
10.1158/0008-5472.CAN-04-0474
Chromosome Transfer Induced Aneuploidy Results in Complex Dysregulation of the Cellular Transcriptome in Immortalized and Cancer Cells
M. Upender (2004)
See more
Semantic Scholar Logo Some data provided by SemanticScholar